PMC:7212965 / 24171-24466 JSONTXT

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T187","span":{"begin":18,"end":20},"obj":"http://purl.obolibrary.org/obo/CLO_0054055"},{"id":"T188","span":{"begin":105,"end":106},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T189","span":{"begin":262,"end":263},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"5 , 67 , 68 , 70, 71, 72, 73 , 76 The pooled prevalence of nausea/vomiting was 7.8% (95% CI, 7.1%–8.5%). A subgroup analysis of 1901 patients from 7 studies (including patients from Germany, Singapore, United States, Australia, and The Netherlands) demonstrated a higher pooled prevalence of 14."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T105","span":{"begin":59,"end":74},"obj":"Phenotype"}],"attributes":[{"id":"A105","pred":"hp_id","subj":"T105","obj":"http://purl.obolibrary.org/obo/HP_0002017"}],"text":"5 , 67 , 68 , 70, 71, 72, 73 , 76 The pooled prevalence of nausea/vomiting was 7.8% (95% CI, 7.1%–8.5%). A subgroup analysis of 1901 patients from 7 studies (including patients from Germany, Singapore, United States, Australia, and The Netherlands) demonstrated a higher pooled prevalence of 14."}

{"project":"2_test","denotations":[{"id":"32407808-32519944-43469288","span":{"begin":9,"end":11},"obj":"32519944"},{"id":"32407808-32217556-43469289","span":{"begin":22,"end":24},"obj":"32217556"}],"text":"5 , 67 , 68 , 70, 71, 72, 73 , 76 The pooled prevalence of nausea/vomiting was 7.8% (95% CI, 7.1%–8.5%). A subgroup analysis of 1901 patients from 7 studies (including patients from Germany, Singapore, United States, Australia, and The Netherlands) demonstrated a higher pooled prevalence of 14."}

{"project":"LitCovid-PubTator","denotations":[{"id":"573","span":{"begin":133,"end":141},"obj":"Species"},{"id":"574","span":{"begin":168,"end":176},"obj":"Species"},{"id":"578","span":{"begin":59,"end":65},"obj":"Disease"},{"id":"579","span":{"begin":66,"end":74},"obj":"Disease"}],"attributes":[{"id":"A573","pred":"tao:has_database_id","subj":"573","obj":"Tax:9606"},{"id":"A574","pred":"tao:has_database_id","subj":"574","obj":"Tax:9606"},{"id":"A578","pred":"tao:has_database_id","subj":"578","obj":"MESH:D009325"},{"id":"A579","pred":"tao:has_database_id","subj":"579","obj":"MESH:D014839"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"5 , 67 , 68 , 70, 71, 72, 73 , 76 The pooled prevalence of nausea/vomiting was 7.8% (95% CI, 7.1%–8.5%). A subgroup analysis of 1901 patients from 7 studies (including patients from Germany, Singapore, United States, Australia, and The Netherlands) demonstrated a higher pooled prevalence of 14."}